Key result
Guideline-concordant MVPA linked to ~25% lower CVD mortality in women, with smaller benefits in men.
Why the study?
Aerobic and muscle-strengthening activities are recommended for cardiovascular prevention, but whether their associations with mortality differ by sex remained unclear.
Does meeting guideline-concordant aerobic and muscle-strengthening physical activity reduce cardiovascular and all-cause mortality differently by sex in U.S. adults?
Cohort
Does meeting guideline-concordant aerobic and muscle-strengthening physical activity reduce cardiovascular and all-cause mortality differently by sex in U.S. adults?
Answers are grounded in this paper and cite their sources.
Both aerobic and muscle-strengthening activities are associated with reduced cardiovascular mortality in men and women, with women experiencing a significantly greater relative risk reduction.
Background Aerobic and muscle-strengthening activities are recommended for cardiovascular prevention, but whether their associations with mortality differ by sex remains unclear. Methods We analyzed U.S. adults in the National Health Interview Survey (1997–2017) linked to the National Death Index through 2019. We estimated propensity scores for meeting guideline-concordant moderate-to-vigorous physical activity (MVPA ≥150 min/week), any vigorous contribution (vigorous physical activity/MVPA; >0%), muscle-strengthening activity (MSA ≥2 sessions/week), and MVPA + MSA using logistic regression including sex and other baseline covariates, and constructed 1 : 1 matched cohorts. Cause-specific Cox models estimated hazard ratios (HRs) for all-cause and cardiovascular disease (CVD) mortality; robust standard errors were clustered by matched pair. In landmark sensitivity analyses, participants with <2 years of follow-up were excluded. Results In matched cohorts, guideline-concordant MVPA was associated with lower CVD mortality in both sexes, with a stronger association in women (men HR 0.857, 95% CI 0.806–0.912; women HR 0.753, 0.705–0.805; P interaction = 0.005). Similar patterns were observed for any vigorous contribution, MSA, and meeting both MVPA and MSA. In landmark analyses, estimates were directionally consistent (e.g. MVPA: men 0.876, 0.821–0.935; women 0.769, 0.718–0.824; P interaction = 0.007). Conclusion MVPA and MSA were associated with lower mortality in men and women. Relative associations for CVD mortality were generally stronger among women, although absolute differences should be interpreted in the context of lower baseline CVD mortality among women. Findings were robust in landmark analyses excluding the first 2 years of follow-up.
No takes yet. Share an insight, caveat, or question.
Shibayama et al. (2026) conducted a cohort in Cardiovascular prevention in the general adult population. Guideline-concordant moderate-to-vigorous physical activity (MVPA ≥150 min/week) and muscle-strengthening activity (MSA ≥2 sessions/week) vs. Not meeting guideline-concordant physical activity levels was evaluated on Cardiovascular disease (CVD) mortality (HR 0.753 (women); HR 0.857 (men), 95% CI 0.705-0.805 (women); 0.806-0.912 (men), p=0.005 for interaction).
Synapse has enriched 10 related papers. Consider them for comparative context: